Since August 2012, Italian general practitioners are required to prescribe the generic name of medicines, except for refill of chronic therapy. We evaluated the extent of switching among equivalents in chronic cardiovascular therapies, the influence of the 2012 regulatory intervention and of patient-related or drug-related factors. Prescriptions of off-patent anti-arrhythmics, oral antidiabetics and ACE inhibitors dispensed from August 2011 to August 2013 within the Bologna Local Health Authority (870,000 inhabitants) was collected. The rate of actual switching among equivalents was evaluated monthly. The effect of the regulatory intervention was estimated by interrupted-time-series analysis. Adjusted odds ratios (aORs) of switching were ca...
Introduction: The appreciable growth in pharmaceutical expenditure has resulted in multiple initiati...
Introduction: The appreciable growth in pharmaceutical expenditure has resulted in multiple initiati...
INTRODUCTION: The appearance of off-patent generic drugs in the world pharmaceutical market is a h...
Since August 2012, Italian general practitioners are required to prescribe the generic name of medic...
Since August 2012, Italian general practitioners are required to prescribe the generic name of medic...
AbstractBackgroundThe use of generics, equivalent but less expensive drugs, is an important opportun...
We study the evolution of statin consumption between 2005-2017 in the Italian region Emilia-Romagna....
To explore long-term changes in intra and inter-class choices between generic compounds, this paper ...
Introduction. The possibility that variation in packaging and pill appearance may reduce adherence i...
OBJECTIVES: To investigate the phenomenon of PPI switching in the acid related disorders treatment i...
OBJECTIVE: The present study investigated the effects of switching to different products of the sam...
Despite the regulatory framework favourable to the use of equivalent medicines in Italy, it remains ...
Background: Antihypertensive drugs play a crucial role in reducing cardiovascular morbidity and mort...
The scientific documentation supporting the potential clinical and economic benefits of a growing us...
The scientific documentation supporting the potential clinical and economic benefits of a growing us...
Introduction: The appreciable growth in pharmaceutical expenditure has resulted in multiple initiati...
Introduction: The appreciable growth in pharmaceutical expenditure has resulted in multiple initiati...
INTRODUCTION: The appearance of off-patent generic drugs in the world pharmaceutical market is a h...
Since August 2012, Italian general practitioners are required to prescribe the generic name of medic...
Since August 2012, Italian general practitioners are required to prescribe the generic name of medic...
AbstractBackgroundThe use of generics, equivalent but less expensive drugs, is an important opportun...
We study the evolution of statin consumption between 2005-2017 in the Italian region Emilia-Romagna....
To explore long-term changes in intra and inter-class choices between generic compounds, this paper ...
Introduction. The possibility that variation in packaging and pill appearance may reduce adherence i...
OBJECTIVES: To investigate the phenomenon of PPI switching in the acid related disorders treatment i...
OBJECTIVE: The present study investigated the effects of switching to different products of the sam...
Despite the regulatory framework favourable to the use of equivalent medicines in Italy, it remains ...
Background: Antihypertensive drugs play a crucial role in reducing cardiovascular morbidity and mort...
The scientific documentation supporting the potential clinical and economic benefits of a growing us...
The scientific documentation supporting the potential clinical and economic benefits of a growing us...
Introduction: The appreciable growth in pharmaceutical expenditure has resulted in multiple initiati...
Introduction: The appreciable growth in pharmaceutical expenditure has resulted in multiple initiati...
INTRODUCTION: The appearance of off-patent generic drugs in the world pharmaceutical market is a h...